knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 15:40:15 - browse：313

Illustration of a bear on a red arrow with a bull underneath pushing the arrow upward. -- biotech coverage from STAT — Adobe

This was supposed to be the year of the biotech comeback, when promising new medicines and high-dollar buyouts would reverse a sector-wide slump that dates back to 2021. Instead, biotech stocks have dramatically underperformed the broader market, and the year’s few green shoots are yet to grow into a turnaround.

The closely watched XBI biotech index has fallen more than 10% in 2023, while the S&P 500 rose about 13% in the same period. Privately held companies have struggled to raise new capital without taking a hit to their valuations, and biotech IPOs have been rare in number and inconsistent in return.

The problem, analysts and investors said, is that the generalist investors who steer trillions of dollars of capital have simply soured on biotech. The furor over novel weight loss medicines like Wegovy has largely been a Big Pharma phenomenon, and rising interest rates have steered fund managers away from risky biotech stocks. The sector has gone through boom and bust cycles in the past, and it’s difficult, if not impossible, to predict when the macro winds might change and make biotech as popular as it was in the early days of Covid-19.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： White House calls on federal agencies to crack down on AI abuses

WSS

Teachers share how revamped forgiveness program helped with their student loans

Recent heat wave in the Mediterranean caused by climate change: Study

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Eisai exec who led development of Alzheimer’s drug to retire

Study: New antibiotic targets gonorrhea as well as last existing drug

White House calls on federal agencies to crack down on AI abuses

entertainment

knowledge

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

Abortion clinic in Cancun will cater to Americans

Medical records are filled with copy

The aspartame in Diet Coke probably isn’t giving you cancer

Affirmative action in medical school literally saved lives

Diversify hospital leadership teams to protect BIPOC patient health

DIEP, the 'gold standard' of breast reconstruction, is under threat

Just how powerful is the placebo effect?

Novavax promises a turnaround & Lilly roils the obesity market

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

hotspot

Create a giant ice tray with this foil pan hack to keep food cold this summer

Sanofi CEO defends move to abandon profit guidance, boost research

Biotech incubator Curie.Bio graduates its first startup

Excited delirium, Elijah McClain, and emergency physicians

Eisai exec who led development of Alzheimer’s drug to retire

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

focus

leisure time

entertainment

Wikipedia